Nathan Reynders

CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6

Andy Chevigné, Bassam Janji, Max Meyrath et al. · Cancers · 2021 · 50 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists

Martyna Szpakowska, Max Meyrath, Nathan Reynders et al. · Biochemical Pharmacology · 2018 · 46 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7

Max Meyrath, Christie B. Palmer, Nathan Reynders et al. · ACS Pharmacology & Translational Science · 2021 · 32 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22

Max Meyrath, Nathan Reynders, Tomasz Uchański et al. · Journal of Leukocyte Biology · 2020 · 28 citations

Life Sciences, Immunology, Molecular Biology +17

The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B

Giulia D’Uonnolo, Nathan Reynders, Max Meyrath et al. · Frontiers in Immunology · 2022 · 22 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17